David Altshuler

EVP, Global Research & Chief Scientific Officer at Vertex Pharmaceuticals

David Altshuler is Executive Vice President, Global Research and Chief Scientific Officer at Vertex Pharmaceuticals. Dr. Altshuler leads Vertex’s research efforts aimed at discovering new medicines for the treatment of CF and other serious diseases, overseeing the company’s three research sites in Boston, San Diego and Oxford, UK.

Links

Previous companies

Org chart

Manager

Reshma Kewalramani

President & CEO

Peers

Charles F. Wagner

EVP, CFO

Amit K. Sachdev

EVP, Chief Patient Officer

Carmen Bozic

EVP, Global Medicines Development & Medical Affairs & Chief Medical Officer

Reports

Colleen O'Brien

Toxicology Research Senior Scientist / CRO Study Monitor

Tudor Fulga

Vice President, Gene Editing

Jason B.

Senior Director And Head, Marketing Science

Mark Bunnage

Senior Vice President & Head Of Global Research At Vertex Pharmaceuticals

Teams

CEO and Executive Team

8 members

Leadership Team

8 members

Timeline

EVP, Global Research & Chief Scientific Officer
Current role

View in org chart